Ownership history in Knott David M Jr · 9 quarters on record
This page tracks every 13F SEC filing in which Knott David M Jr reported a position in Catalyst Pharmaceuticals, Inc. (CPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 189,000 | — | 0% | 2.04% | $4.4M | $23.34 |
| 2025 Q3 | ADDED | 189,000 | +13,000 | +7.4% | 1.50% | $3.7M | $19.70 |
| 2025 Q2 | REDUCED | 176,000 | -36,000 | -17.0% | 1.73% | $3.8M | $21.70 |
| 2025 Q1 | ADDED | 212,000 | +2,000 | +1.0% | 2.43% | $5.1M | $24.25 |
| 2024 Q4 | REDUCED | 210,000 | -2,000 | -0.9% | 1.58% | $4.4M | $20.87 |
| 2024 Q3 | UNCHANGED | 212,000 | — | 0% | 1.48% | $4.2M | $19.88 |
| 2024 Q2 | ADDED | 212,000 | +24,148 | +12.9% | 1.31% | $3.3M | $15.49 |
| 2024 Q1 | ADDED | 187,852 | +62,402 | +49.7% | 1.06% | $3.0M | $15.94 |
| 2023 Q4 | INITIATED | 125,450 | — | — | 0.81% | $2.1M | — |
As of 2025 Q4 — sorted by position size